"Nos médecins oncologues et radiologues vous accueillent de lundi au vendredi pour tous types de soins médicaux. Pour prendre un rendez-vous, contactez le secrétariat."

During the past decade, Centre Catalan D'Oncologie conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 4 clinical trials were completed, i.e. on average, 57.1% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 3 clinical trials were completed. i.e. 300% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Centre Catalan D'Oncologie" #1 sponsor was "Hoffmann-La Roche" with 6 trials, followed by "Intergroupe Francophone de Cancerologie Thoracique" with 3 trials sponsored, "UNICANCER" with 3 trials sponsored, "ARCAGY/ GINECO GROUP" with 2 trials sponsored and "AGO Research GmbH" with 2 trials sponsored. Other sponsors include 6 different institutions and companies that sponsored additional 16 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Centre Catalan D'Oncologie" #1 collaborator was "AstraZeneca" with 2 trials as a collaborator, "Groupe Francais De Pneumo-Cancerologie" with 2 trials as a collaborator, "ARCAGY/ GINECO GROUP" with 1 trials as a collaborator, "Arbeitsgemeinschaft Gynaekologische Onkologie Austria" with 1 trials as a collaborator and "Australia New Zealand Gynaecological Oncology Group" with 1 trials as a collaborator. Other collaborators include 1 different institutions and companies that were collaborators in the rest 11 trials.

According to Clinical.Site data, the most researched conditions in "Centre Catalan D'Oncologie" are "Breast Cancer" (4 trials), "Metastatic Breast Cancer" (3 trials), "Bone Metastases" (2 trials), "Carcinoma, Non-Small-Cell Lung" (2 trials) and "Colorectal Cancer" (2 trials). Many other conditions were trialed in "Centre Catalan D'Oncologie" in a lesser frequency.

Most popular intervention types in "Centre Catalan D'Oncologie" are "Drug" (16 trials), "Radiation" (7 trials), "Other" (2 trials), "Procedure" (2 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Bevacizumab" (3 trials), "Pemetrexed" (2 trials), "Trastuzumab" (2 trials), "Accelerated partial breast irradiation" (1 trials) and "Aromatase Inhibitors" (1 trials). Other intervention names were less common.

The vast majority of trials in "Centre Catalan D'Oncologie" are 18 trials for "All" genders and 8 trials for "Female" genders.

Currently, there are NaN active trials in "Centre Catalan D'Oncologie". undefined are not yet recruiting, 3 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 17 completed trials in Centre Catalan D'Oncologie, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Centre Catalan D'Oncologie, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 14 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 1 trials that are defined as “Not Applicable".